{"disease":{"id":"tumor-associated-lymph-node-t-cell","name":"tumor associated lymph node t cell"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06716619","title":"A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":32,"lead_sponsor_name":"Guangzhou FineImmune Biotechnology Co., LTD.","has_results":false},{"nct_id":"NCT06302062","title":"Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":23,"lead_sponsor_name":"Guangzhou FineImmune Biotechnology Co., LTD.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}